Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00705913 · ClinicalTrials.gov registry record · NA
Randomized Sizing and Hemodynamic Study Mitroflow vs. Magna
A NA study, sponsored by Sorin Group USA.
- Terminated
- Registry status
- NA
- Development phase
- 368
- Enrollment target
NCT00705913 is a NA study that was terminated before completion, run by Sorin Group USA. The registered enrollment target is 368 participants.
The verdict
NCT00705913, a NA study, was terminated before completion, sponsored by Sorin Group USA.
- TERMINATED
- Registry status
- NA
- Development phase
- 368 participants
- Enrollment target
Study Summary
The purpose of this study is to compare sizing,implant techniques, and hemodynamics between the Mitroflow Pericardial Aortic Valve and the Edwards Magna Heart Valve.
Interventions
- DEVICE Mitroflow Aortic Pericardial Heart Valve (CarboMedics)
- DEVICE Carpentier-Edwards Magna Tissue Valve
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 368 participants |
| Start Date | 2008-06 |
| Est. Completion | 2011-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00705913
The ClinicalTrials.gov registry entry for NCT00705913 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 368 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sorin Group USA, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Mitroflow Aortic Pericardial Heart Valve (CarboMedics) is the first listed.
NCT00705913 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00705913 about?
NCT00705913 is a clinical study titled "Randomized Sizing and Hemodynamic Study Mitroflow vs. Magna". The purpose of this study is to compare sizing,implant techniques, and hemodynamics between the Mitroflow Pericardial Aortic Valve and the Edwards Magna Heart Valve.
What is the current status of trial NCT00705913?
This trial is currently terminated. It is a NA study. The enrollment target is 368 participants. The study started on 2008-06. Estimated completion is 2011-09.
What interventions are being tested in trial NCT00705913?
The interventions under investigation include: Mitroflow Aortic Pericardial Heart Valve (CarboMedics) (DEVICE), Carpentier-Edwards Magna Tissue Valve (DEVICE).
Who is sponsoring clinical trial NCT00705913?
This trial is sponsored by Sorin Group USA, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.